Published in Am J Med on December 01, 1976
Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev (2008) 3.52
Candida infections in surgical patients. Ann Surg (1983) 1.63
Estimations of serum arabinitol for diagnosing invasive candidosis. J Clin Pathol (1986) 1.27
Candida infections in surgical patients. Dose requirements and toxicity of amphotericin B. Ann Surg (1982) 1.09
Candida in acute pancreatitis. Surg Today (2007) 1.06
Paecilomyces variotii in peritoneal dialysate. J Clin Microbiol (1993) 0.98
Current Concepts in the Management of Fungal Peritonitis. Curr Infect Dis Rep (2003) 0.95
Candida peritonitis: an update on the latest research and treatments. World J Surg (2011) 0.90
Intra-Abdominal Candidiasis: The Importance of Early Source Control and Antifungal Treatment. PLoS One (2016) 0.87
Experimental intraabdominal candidiasis in rabbits: therapy with low-total-dose intravenous amphotericin B. Antimicrob Agents Chemother (1981) 0.82
Fungal peritonitis caused by Lecythophora mutabilis. J Clin Microbiol (1985) 0.82
Early presumptive therapy with fluconazole for occult Candida infection after gastrointestinal surgery. World J Surg (2006) 0.81
Therapy of Candida peritonitis: penetration of amphotericin B into peritoneal fluid. Postgrad Med J (1978) 0.78
Systemic Candida infections. Yale J Biol Med (1998) 0.75
Effective photodynamic therapy against microbial populations in human deep tissue abscess aspirates. Lasers Surg Med (2013) 0.75
Peritoneal clearance of amphotericin B and 5-fluorocytosine. West J Med (1980) 0.75
Diagnosis and management of infective endocarditis and its complications. Circulation (1999) 4.77
Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest (1994) 4.39
Klebsiella in faecal flora of renal-transplant patients. Lancet (1970) 3.14
Susceptibility of anaerobic bacteria to metronidazole: relative resistance of non-spore-forming gram-positive baccilli. J Infect Dis (1975) 3.11
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol (1998) 3.04
Epidemiology of cytomegalovirus infection after transplantation and immunosuppression. J Infect Dis (1975) 3.02
Ocular manifestations of Candida septicemia: review of seventy-six cases of hematogenous Candida endophthalmitis. Medicine (Baltimore) (1974) 2.97
Epidemiology of Klebsiella and hospital-associated infections. Rev Infect Dis (1980) 2.77
Renal artery embolism: clinical features and long-term follow-up of 17 cases. Ann Intern Med (1978) 2.72
Pyogenic vertebral osteomyelitis: report of nine cases and review of the literature. Rev Infect Dis (1980) 2.72
The use of the catalase test to detect significant bacteriuria. Am J Med Sci (1966) 2.66
Serious infections in adults due to group B streptococci. Clinical and serotypic characterization. Am J Med (1976) 2.58
In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci. Antimicrob Agents Chemother (1973) 2.58
Partial characterization and staphylocidal activity of thrombin-induced platelet microbicidal protein. Infect Immun (1992) 2.53
Reticulum cell sarcoma after renal homotransplantation and azathioprine and prednisone therapy. Br Med J (1968) 2.52
Enterococci highly resistant to penicillin and ampicillin: an emerging clinical problem? J Clin Microbiol (1989) 2.51
Lactobacillemia--report of nine cases. Important clinical and therapeutic considerations. Am J Med (1978) 2.46
Intravenous calcitriol in the treatment of refractory osteitis fibrosa of chronic renal failure. N Engl J Med (1989) 2.40
Hyperproduction of alpha-hemolysin in a sigB mutant is associated with elevated SarA expression in Staphylococcus aureus. Infect Immun (1999) 2.35
Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest (1998) 2.29
Bacteroidaceae bacteremia: clinical experience with 112 patients. Medicine (Baltimore) (1974) 2.21
Effect of thrombocytopenia on the early course of streptococcal endocarditis. J Infect Dis (1993) 2.18
Renal failure and infection. Medicine (Baltimore) (1968) 2.16
Pulmonary aspergilloma. Diagnostic and therapeutic considerations. Arch Intern Med (1983) 2.13
Acute interstitial nephritis due to methicillin. Am J Med (1978) 2.11
Transesophageal echocardiography in diagnosis of infective endocarditis. Chest (1994) 2.11
Topical treatment of cutaneous lesions of acquired immunodeficiency syndrome-related Kaposi sarcoma using alitretinoin gel: results of phase 1 and 2 trials. Arch Dermatol (2000) 2.09
Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother (1989) 2.05
Herpes-simplex-virus infection after renal transplantation. Lancet (1969) 2.03
Circulating immune complexes in infective endocarditis. N Engl J Med (1976) 2.02
Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med (1981) 2.00
Group D enterococcal meningitis. Clinical and therapeutic considerations with report of three cases and review of the literature. Arch Intern Med (1976) 1.98
Variables in demonstrating methicillin tolerance in Staphylococcus aureus strains. Antimicrob Agents Chemother (1982) 1.97
Purification and in vitro activities of rabbit platelet microbicidal proteins. Infect Immun (1997) 1.96
Anorectal gonococcal infection. Ann Intern Med (1977) 1.96
Role of the sar locus of Staphylococcus aureus in induction of endocarditis in rabbits. Infect Immun (1994) 1.92
Recombinant human erythropoietin for patients with AIDS treated with zidovudine. N Engl J Med (1990) 1.89
Staphylococcus aureus susceptibility to thrombin-induced platelet microbicidal protein is independent of platelet adherence and aggregation in vitro. Infect Immun (1992) 1.84
Characterization of Staphylococcus aureus-platelet binding by quantitative flow cytometric analysis. J Infect Dis (1992) 1.84
Quantitation of amphotericin B with use of high-pressure liquid chromatography. J Infect Dis (1977) 1.83
In vitro resistance to platelet microbicidal protein correlates with endocarditis source among bacteremic staphylococcal and streptococcal isolates. Antimicrob Agents Chemother (1994) 1.83
Thrombin-induced rabbit platelet microbicidal protein is fungicidal in vitro. Antimicrob Agents Chemother (1993) 1.80
Staphylocidal action of thrombin-induced platelet microbicidal protein is not solely dependent on transmembrane potential. Infect Immun (1996) 1.79
Susceptibility of herpesviruses to cytosine arabinoside: standardization of susceptibility test procedure and relative resistance of herpes simplex type 2 strains. Antimicrob Agents Chemother (1972) 1.79
Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations. J Infect Dis (1985) 1.78
In vitro antibacterial activities of platelet microbicidal protein and neutrophil defensin against Staphylococcus aureus are influenced by antibiotics differing in mechanism of action. Antimicrob Agents Chemother (1999) 1.77
Susceptibility of herpesviruses to three nucleoside analogues and their combinations and enhancement of the antiviral effect of acid pH. J Infect Dis (1974) 1.74
Effect of NaCl infusion on urinary Ca++ and Mg++ during reduction in their filtered loads. Am J Physiol (1967) 1.72
Selective activation of sar promoters with the use of green fluorescent protein transcriptional fusions as the detection system in the rabbit endocarditis model. Infect Immun (1998) 1.72
Inadvertent aluminum administration during plasma exchange due to aluminum contamination of albumin-replacement solutions. N Engl J Med (1985) 1.68
Comparative susceptibility of anaerobic bacteria to ticarcillin, cefoxitin, metronidazole, and related antimicrobial agents. Antimicrob Agents Chemother (1977) 1.67
Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob Agents Chemother (1991) 1.67
Intractable pruritus as a manifestation of secondary hyperparathyroidism in uremia. Disappearance of itching after subtotal parathyroidectomy. N Engl J Med (1968) 1.66
Transplantation of cadaveric kidneys from patients with hepatorenal syndrome. Evidence for the functionalnature of renal failure in advanced liver disease. N Engl J Med (1969) 1.64
IgG rheumatoid factor in subacute bacterial endocarditis: relationship to IgM rheumatoid factor and circulating immune complexes. Clin Exp Immunol (1978) 1.62
Spontaneous bacterial peritonitis. Hepatology (1982) 1.61
Synergism of amphotericin B and 5-fluorocytosine for candida species. J Infect Dis (1975) 1.61
Platelet microbicidal protein enhances antibiotic-induced killing of and postantibiotic effect in Staphylococcus aureus. Antimicrob Agents Chemother (1992) 1.59
Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline. Antimicrob Agents Chemother (1975) 1.59
Cephalothin and cephaloridine therapy for bacterial meningitis. Ann Intern Med (1975) 1.58
Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus. Antimicrob Agents Chemother (1984) 1.57
Serious infections due to group G streptoccocci. Report of 15 cases with in vitro-in vivo correlations. Am J Med (1983) 1.57
Long-term Pseudomonas colonization in spinal cord injury patients. Am J Epidemiol (1980) 1.56
Necrotizing pneumonia and empyema due to Clostridium perfringens. Report of a case and review of the literature. Am J Med (1975) 1.56
Hematogenous candida endophthalmitis in patients receiving parenteral hyperalimentation fluids. J Infect Dis (1981) 1.56
Role of anaerobic bacteria in spontaneous peritonitis of cirrhosis: report of two cases and review of the literature. Am J Med (1977) 1.53
Phenotypic resistance to thrombin-induced platelet microbicidal protein in vitro is correlated with enhanced virulence in experimental endocarditis due to Staphylococcus aureus. Infect Immun (1997) 1.51
Insertional inactivation of a chromosomal locus that modulates expression of potential virulence determinants in Staphylococcus aureus. J Bacteriol (1995) 1.47
The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol (1975) 1.46
Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun (1996) 1.45
Pseudomonas colonization in patients with spinal cord injury. Am J Epidemiol (1978) 1.45
Study of intestinal absorption of calcium in patients with renal failure. Kidney Int (1973) 1.45
Sepsis associated with decubitus ulcers. Am J Med (1976) 1.44
Maintenance peritoneal dialysis as an alternative in the patient with diabetes mellitus and end-stage uremia. Kidney Int Suppl (1974) 1.43
Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis (1978) 1.43
Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis (1991) 1.43
Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa. Antimicrob Agents Chemother (1985) 1.42
Role of anaerobic bacteria in subdural empyema. Report of four cases and review of 327 cases from the English literature. Am J Med (1975) 1.39
Action of 1,25-dihydroxycholecalciferol, a potent, kidney-produced metabolite of vitamin D, in uremic man. N Engl J Med (1972) 1.39
Resistance to platelet microbicidal protein results in increased severity of experimental Candida albicans endocarditis. Infect Immun (1996) 1.39
Pyelonephritis. XII. Comparison of penicillin, ampicillin, and streptomycin in enterococcal infection in rats. J Infect Dis (1971) 1.39